Zona pellucida induces activation of phospholipase A2 during acrosomal exocytosis in guinea pig spermatozoa. 2003

Y Y Yuan, and W Y Chen, and Q X Shi, and L Z Mao, and S Q Yu, and X Fang, and E R S Roldan
Zhejiang Academy of Medical Sciences, Hangzhou, Zhejiang 310013, People's Republic of China.

Phospholipase A(2) (PLA(2)) is activated in spermatozoa in response to progesterone and Ca(2+) ionophores, but to our knowledge, no study has yet reported zona pellucida (ZP)-induced activation of PLA(2). We investigated whether PLA(2) is involved in ZP-stimulated acrosomal exocytosis, if Ca(2+) is required for activation of PLA(2), and signal transduction pathways modulating PLA(2) using guinea pig sperm as a model. Spermatozoa were capacitated and labeled in low-Ca(2+) medium with [(14)C]choline chloride or [(14)C]arachidonic acid and were then exposed to millimolar Ca(2+) and various reagents and stimulated with ZP. Precapacitated spermatozoa exposed to millimolar Ca(2+) and stimulated with ZP experienced increases in arachidonic acid (AA) and lysophosphatidylcholine (lysoPC) levels and a parallel decrease in phosphatidylcholine level; these changes are indicative of PLA(2) activation. Simulation with ZP also led to acrosomal exocytosis in a high proportion of spermatozoa. Lipid changes and exocytosis were prevented if spermatozoa were exposed to aristolochic acid, a PLA(2) inhibitor, before treatment with ZP. Stimulation with ZP in medium without added Ca(2+) or in medium with millimolar Ca(2+) and EGTA or La(3+) resulted in no lipid changes or exocytosis. Pretreatment with pertussis toxin, a G(i) protein inhibitor, before stimulation with ZP blocked the release of AA and lysoPC as well as acrosomal exocytosis. Exposure of spermatozoa to the diacylglycerol (DAG) kinase inhibitor R59022 before ZP stimulation led to a significant increase in generation of lysoPC and exocytosis. Taken together, these results indicate very strongly that PLA(2) plays an essential role in ZP-induced exocytosis in spermatozoa, that PLA(2) activation requires Ca(2+) internalization, and that PLA(2) activation is regulated by signal transduction pathways involving G proteins and DAG.

UI MeSH Term Description Entries
D007811 Lanthanum The prototypical element in the rare earth family of metals. It has the atomic symbol La, atomic number 57, and atomic weight 138.91. Lanthanide ion is used in experimental biology as a calcium antagonist; lanthanum oxide improves the optical properties of glass.
D008244 Lysophosphatidylcholines Derivatives of PHOSPHATIDYLCHOLINES obtained by their partial hydrolysis which removes one of the fatty acid moieties. Lysolecithin,Lysolecithins,Lysophosphatidylcholine
D008297 Male Males
D010741 Phospholipases A Phospholipases that hydrolyze one of the acyl groups of phosphoglycerides or glycerophosphatidates.
D011744 Pyrimidinones Heterocyclic compounds known as 2-pyrimidones (or 2-hydroxypyrimidines) and 4-pyrimidones (or 4-hydroxypyrimidines) with the general formula C4H4N2O. Pyrimidinone,Pyrimidone,Pyrimidones
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002614 Chelating Agents Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. Chelating Agent,Chelator,Complexons,Metal Antagonists,Chelators,Metal Chelating Agents,Agent, Chelating,Agents, Chelating,Agents, Metal Chelating,Antagonists, Metal,Chelating Agents, Metal
D004533 Egtazic Acid A chelating agent relatively more specific for calcium and less toxic than EDETIC ACID. EGTA,Ethylene Glycol Tetraacetic Acid,EGATA,Egtazic Acid Disodium Salt,Egtazic Acid Potassium Salt,Egtazic Acid Sodium Salt,Ethylene Glycol Bis(2-aminoethyl ether)tetraacetic Acid,Ethylenebis(oxyethylenenitrile)tetraacetic Acid,GEDTA,Glycoletherdiamine-N,N,N',N'-tetraacetic Acid,Magnesium-EGTA,Tetrasodium EGTA,Acid, Egtazic,EGTA, Tetrasodium,Magnesium EGTA
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme

Related Publications

Y Y Yuan, and W Y Chen, and Q X Shi, and L Z Mao, and S Q Yu, and X Fang, and E R S Roldan
July 2010, Human reproduction (Oxford, England),
Y Y Yuan, and W Y Chen, and Q X Shi, and L Z Mao, and S Q Yu, and X Fang, and E R S Roldan
May 2005, Molecular human reproduction,
Y Y Yuan, and W Y Chen, and Q X Shi, and L Z Mao, and S Q Yu, and X Fang, and E R S Roldan
September 2010, Reproductive biology and endocrinology : RB&E,
Y Y Yuan, and W Y Chen, and Q X Shi, and L Z Mao, and S Q Yu, and X Fang, and E R S Roldan
November 1996, FEBS letters,
Y Y Yuan, and W Y Chen, and Q X Shi, and L Z Mao, and S Q Yu, and X Fang, and E R S Roldan
March 1998, The Biochemical journal,
Y Y Yuan, and W Y Chen, and Q X Shi, and L Z Mao, and S Q Yu, and X Fang, and E R S Roldan
January 2012, Journal of andrology,
Y Y Yuan, and W Y Chen, and Q X Shi, and L Z Mao, and S Q Yu, and X Fang, and E R S Roldan
March 1993, The Journal of biological chemistry,
Y Y Yuan, and W Y Chen, and Q X Shi, and L Z Mao, and S Q Yu, and X Fang, and E R S Roldan
December 1994, Science (New York, N.Y.),
Y Y Yuan, and W Y Chen, and Q X Shi, and L Z Mao, and S Q Yu, and X Fang, and E R S Roldan
July 1998, The American journal of physiology,
Y Y Yuan, and W Y Chen, and Q X Shi, and L Z Mao, and S Q Yu, and X Fang, and E R S Roldan
August 1984, Experimental cell research,
Copied contents to your clipboard!